Slow Bull
The market, slowly. FRIDAY, 25 SEPTEMBER 2026
← All news
Markets

Ionis’ rare neurology drug approved; Pfizer inks an ADC deal

1 source ·1 article ·Sep 4, 13:00 UTC Agree Realty Pfizer

Zanvastro is now the first approved medicine for Alexander disease. Elsewhere, an immune system specialist posted positive results and a cell therapy developer turned to layoffs.

Covered by 1 outlet

Biopharmadive 1

All coverage · 1 article

BioPharma Dive ·Sep 4, 13:00 UTC

Ionis’ rare neurology drug approved; Pfizer inks an ADC deal

Zanvastro is now the first approved medicine for Alexander disease. Elsewhere, an immune system specialist posted positive results and a cell therapy developer turned to layoffs.